课题基金 / 基金详情

Influence of various types of receptor tyrosine kinase gene mutations in pathogenesis of GISTs

Influence of various types of receptor tyrosine kinase gene mutations in pathogenesis of GISTs
各类受体酪氨酸激酶基因突变对GIST发病的影响
批准号:
23390094
负责人:
HIROTA Seiichi
金额:
$12.65万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2011
资助国家:
日本
项目状态:
已结题
起止时间:
2011-04-01 至 2014-03-31

项目摘要

项目成果

HIROTA Seiichi的其他基金

相关文献

中文摘要
翻译
激酶结构域II纯合突变敲入小鼠肥大细胞培养的永生化肥大细胞系激活的信号转导系统与敲入小鼠培养的激酶结构域II纯合突变敲入小鼠肥大细胞激活的信号转导系统不同。永生化肥大细胞系在c-kit基因中有一个额外的突变。伊马替尼和尼洛替尼可有效抑制家族性gist中新发现的近膜结构域种系c-kit基因功能获得突变的激活。我们还发现,与常规的细胞外结构域c-kit基因突变相比,伊马替尼和尼洛替尼有效地抑制了散发性gist中新发现的细胞外结构域c-kit基因突变的激活。
英文摘要
Signal transduction system activated in immortalized mast cell line which is derived from cultured mast cells of knock-in mice with germline homozygous mutation at kinase domain II was different from that in cultured mast cells of knock-in mice with germline homozygous mutation. The immortalized mast cell line had an additional mutation in the c-kit gene.Activation of newly found juxtamembrane domain germline c-kit gene gain-of-function mutation in familial GISTs was effectively inhibited by imatinib and nilotinib. We also found that activation of newly found extracellular domain c-kit gene mutation in sporadic GISTs is effectively inhibited by imatinib and nilotinib, compared to that of conventional extracellular domain c-kit gene mutation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1007/s10147-011-0339-7
发表时间: 2013-02-01
期刊: INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY
影响因子: 3.3
作者: [Kanda, Tatsuo, Nishida, Toshirou, Ohtsu, Atsushi]
通讯作者: Ohtsu, Atsushi
DOI: 10.4251/wjgo.v4.i5.119
发表时间: 2012-05-15
期刊: WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY
影响因子: 3
作者: [Murayama, Yoko, Yamamoto, Masayuki, Hiratsuka, Masahiro]
通讯作者: Hiratsuka, Masahiro
Good clinical response to imatinib mesylate in atypical thymic carcinoid with KIT overexpression
甲磺酸伊马替尼治疗 KIT 过度表达的非典型胸腺类癌具有良好的临床反应
DOI: 10.1200/jco.2010.30.2455
发表时间: 2011
期刊: J Clin Oncol
影响因子: 45.3
作者: [Hamada S, Masago K, Mio T, Hirota S, Mishima M]
通讯作者: Mishima M
DOI: 10.1007/s00795-011-0568-x
发表时间: 2012
期刊: Med Mol Morphol
影响因子: 1.8
作者: [Hirano H, Yoshida T, Yoshimura H, Fukuoka M, Ohmura N, Nishizawa Y, Tachibana S, Hirota S, Zozumi M, Nishigami T]
通讯作者: Nishigami T
15
    A study of secondary resistance mechanism for molecular target drugs in gastrointestinal stromal tumors
    • 批准号:
      19590410
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.83万
    • 财政年份:
      2007
    • 负责人:
      HIROTA Seiichi
    • 依托单位:
    Analysis of abnormal signaling through KIT and PDGFRA in development of gastrointestinal stromal tumors
    • 批准号:
      17013082
    • 项目类别:
      Grant-in-Aid for Scientific Research on Priority Areas
    • 资助金额:
      $30.08万
    • 财政年份:
      2005
    • 负责人:
      HIROTA Seiichi
    • 依托单位:
    Pathological analysis of GIST using transgenic or knock-in-mouse
    Analysis of familial and multiple GIST